Strengthening and transforming the pharmaceutical supply chain
European Pharmaceutical Review
JULY 21, 2023
Recommendations were also published earlier this year for all stakeholders in the pharma supply chain. In this Q&A EPR speaks to Naser Al Yammahi the Deputy CEO of Hayat Biotech about pharmaceutical supply chain challenges and how they can be addressed. Globalisation and supply chain complexity are a factor.
Let's personalize your content